Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events

PURPOSE: To capture UK societal health utility values for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and the disutility associated with treatment-related adverse events (AEs) to inform future cost–utility analyses. METHODS: A literature review, and patient and clinical expert int...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, F., de Freitas, H. M., Kerr, C., Ito, T., Nafees, B., Lloyd, A. J., Penton, J., Hadi, M., Lanar, S., Pham, T. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470112/
https://www.ncbi.nlm.nih.gov/pubmed/30767088
http://dx.doi.org/10.1007/s11136-019-02117-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470112/
https://www.ncbi.nlm.nih.gov/pubmed/30767088
http://dx.doi.org/10.1007/s11136-019-02117-9

Ejemplares similares